Compare DigitalOcean Holdings Inc (DOCN) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DigitalOcean Holdings Inc vs Novavax Inc — how do they compare? DigitalOcean Holdings Inc trades at $134.82 (market cap $14.57B), while Novavax Inc trades at $12.75 (market cap $1.82B). The key difference: DigitalOcean Holdings Inc is far larger — about 8× Novavax Inc's market cap, and Novavax Inc is trading nearer its 52-week high, DigitalOcean Holdings Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold DigitalOcean Holdings Inc for 43 Days and Novavax Inc for 59 Days on average.
| DOCN | NVAX | |
|---|---|---|
Market Cap | $14.57B | $1.82B |
Volume | 2,261,786 | 6,198,505 |
Sector | Technology | Health |
52-Week High | $181.29 | $12.56 |
52-Week Low | $37.30 | $6.22 |
Typical Hold Time | 43 Days | 59 Days |
Enterprise Value | $15.33B | $1.39B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DigitalOcean (DOCN) trades at $134.82, up 5.92% today, showing strong momentum with three consecutive quarterly earnings beats. The stock exhibits bullish technical signals with RSI levels in oversold territory, while fundamentals reveal impressive revenue growth from $576M in 2022 to $901M in 2025, with net income turning positive at $259M. Recent announcements include new AI-focused Agent Droplets and a $725M equipment financing facility to support capacity expansion.
DOCN presents growth potential with strong analyst support (68% buy ratings) and a $172.73 consensus price target, though elevated valuation ratios (P/E 56.32, P/S 13.96) and negative shareholder equity pose risks. The company's AI-native cloud strategy shows promise, but execution risks and competitive pressures in the cloud infrastructure space require monitoring.
Novavax (NVAX) trades at $12.75, up 13.64% with strong technical momentum and bullish moving averages. The company shows mixed fundamentals with revenue of $1.12B in 2025 and positive net income of $440.30M, though 2026 projections indicate a return to losses. Recent news highlights regulatory approvals for its COVID-19 vaccine and strategic pivot toward Matrix-M adjuvant licensing partnerships.
The outlook remains speculative with high volatility. Opportunities include partnership-driven growth and vaccine demand, but risks involve consistent profitability challenges, high debt-to-asset ratios, and competitive pressures. Analyst sentiment is predominantly bullish (73.9% buy ratings), yet investors should weigh the company's transition phase against financial stability concerns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DigitalOcean Holdings Inc
DigitalOcean Holdings Inc is a cloud computing platform offering on-demand infrastructure and platform tools for developers, start-ups and small and medium-sized businesses. The customers use the platform for a wide range of cases, such as web and mobile applications, website hosting, e-commerce, media and gaming, personal web projects, and managed services, among many others. The group has a business presence in North America, Europe, Asia and other countries.
Read more on DOCN →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
